Company profile
CavGene Therapeutics company profile
CavGene utilizes gene therapy to treat levodopa induced dyskinesia (LID) in patients with Parkinson’s Disease.
Business identity
- Website
- https://cavgene.com
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 11-50 employees
- Revenue range
- $0+
- Founded
- 2022-11-01, Month
Headquarters
- Headquarters
- East Lansing, Michigan, United States
- Country code
- US
- Continent
- North America